- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/26 - X and Y being nitrogen atoms, i.e. biguanides
Patent holdings for IPC class C07C 279/26
Total number of patents in this class: 189
10-year publication summary
|
25
|
16
|
22
|
13
|
12
|
9
|
7
|
8
|
4
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immunomet Therapeutics Inc. | 31 |
15 |
| Hanall Biopharma Co., Ltd. | 90 |
11 |
| Anji Pharmaceuticals Inc. | 31 |
10 |
| Centre National de La Recherche Scientifique | 11092 |
5 |
| Institut Curie | 621 |
5 |
| The Regents of the University of California | 20868 |
4 |
| FUJIFILM Wako Pure Chemical Corporation | 192 |
4 |
| Mesosil Inc. | 10 |
4 |
| BASF SE | 21328 |
3 |
| Merck Patent GmbH | 5742 |
3 |
| Bayer Cropscience AG | 1833 |
3 |
| Wako Pure Chemical Industries, Ltd. | 118 |
3 |
| 1Globe Biomedical Co., Ltd. | 31 |
3 |
| 1Globe Health Institute LLC | 39 |
3 |
| ADAMA Agan Ltd. | 447 |
3 |
| The Catholic University of Korea Industry-academic Cooperation Foundation | 877 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3325 |
3 |
| Laboratorios Silanes S.A. de C.V. | 47 |
3 |
| Ovid Therapeutics Inc | 179 |
3 |
| Queen Mary University of London | 267 |
3 |
| Other owners | 95 |